Individuals with treatment-resistant depression do not achieve and sustain remission after multiple pharmacotherapies, with an unknown impact on employment. This study investigates the expenditures of TRD from a private-payer perspective in Canada.
Jamie Kellar, PharmD
Advertisement
Articles by Jamie Kellar, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 Vaccination in Medically Complex Adults
2
FDA Grants Accelerated Approval to Iberdomide Combination for Multiple Myeloma
3
Generic Semaglutide May Make GLP-1 Therapy Cost-Effective in T2D
4
Active Surveillance Becomes Dominant Strategy for Low-Risk Prostate Cancer, Reaching 93% Among Veterans
5